Supplementary to the parent R01GM123037 ?Integrative approach to studying LncRNA functions? The recent studies showed that lncRNAs were involved in many neurological diseases such as Alzheimer's disease (AD). First, lncRNAs impact AD pathogenesis because of their diverse functional effects from the epigenetic regulation. For example, ?-site amyloid precursor protein cleaving enzyme-1 antisense transcript (BACE1-AS) is the lncRNA transcribed from the opposite strand of ? -site APP cleaving enzyme-1 (BACE1) locus. Cell stress increased BACE1-AS levels, which in turn stimulates BACE1 expression, which could enhance APP processing and Ab1-42 production. Elevated Ab1-42 levels can further promote BACE1-AS overexpression and the APP processing cascade in a feedforward manner. Second, accumulating evidence shows that microRNAs play a critical role in the pathogenesis of AD. From the fact that ~ 90% of the SNPs associated with diseases are located in non-coding regions and lncRNA plays a role as a sponge of miRNAs, RNA-level editing, which has the similar effect as the single nucleotide variant in lncRNA, can result in aberrant gene expression regulation in AD. Third, another pathogenic post-transcriptional modification in lncRNA is the alternative splicing (AS). 17A mapped in intron 3 of G-protein-coupled receptor 51 gene (GPR51) undergoes AS. 17A lncRNA is upregulated in AD compared with control and AS event in 17A impairs the GABA B signaling, enhance A? secretion. The role and functions of the known lncRNAs have been accumulated. However, there is no deep functional annotation of post-transcriptionally modified lncRNAs that have RNA- editing or alternative splicing events in the AD. Therefore, there is an urgent need to develop new tools for analyzing the potential functional impact of the post-transcriptionally modified lncRNA systemically in the AD genome and predict their regulatory mechanisms. Here, we propose to develop an integrated system for transcriptomic sequencing data-based functional annotation of post-transcriptional modification events of lncRNAs in AD based on the AD sequencing data from ADSP consortium and other NIH controlled AD data sets. Our multidisciplinary team proposed the following aims: (1) We will develop functional mechanism prediction of lncRNAs' RNA-editing events through investigating the gain/loss of the binding sites of miRNAs, which targeting AD genes (we integrated ~ 1,500 AD genes.), due to RNA-editing with checking the expressional impact between RNA-editing +/- groups and studying the changed relative energy of lncRNA secondary structures. (2) We will develop functional mechanism prediction of lncRNAs' AS events through identifying AD-specific/associated AS events in lncRNAs, correlated lncRNA expressions with AD genes' AS isoforms, investigating the gain/loss of miRNA binding sites due to AS event, and SNP/SV-induced AS events. Our study will be focused on AD-related lncRNAs to identify epigenetic impact of these on AD genes and AD pathogenic mechanisms. This supplementary is within the scope of parent R01GM123037 where we proposed to develop Bioinformatics tools to study lncRNA functions for cancer.

Public Health Relevance

We propose to develop an integrated system for transcriptomic sequencing data-based functional annotation of post-transcriptional modification (PtM) events of lncRNAs in AD based on the AD sequencing data from ADSP consortium and other NIH controlled AD data sets. Successful completion of this study will explain the pathogenic mechanism of AD in the non-coding regions. Our work will provide important prognostic insights and advancing therapeutic strategies that address the complexity of AD.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM123037-04S1
Application #
10119971
Study Section
Biodata Management and Analysis Study Section (BDMA)
Program Officer
Brazhnik, Paul
Project Start
2017-09-15
Project End
2021-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas Health Science Center Houston
Department
Type
Sch Allied Health Professions
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77030
Adjeroh, Donald; Allaga, Maen; Tan, Jun et al. (2018) Feature-Based and String-Based Models for Predicting RNA-Protein Interaction. Molecules 23:
Xu, Yungang; Zhao, Weiling; Olson, Scott D et al. (2018) Alternative splicing links histone modifications to stem cell fate decision. Genome Biol 19:133
Chyr, Jacqueline; Guo, Dongmin; Zhou, Xiaobo (2018) LSCC SNP variant regulates SOX2 modulation of VDAC3. Oncotarget 9:22340-22352
Luo, Jiesi; Liu, Liang; Venkateswaran, Suresh et al. (2017) RPI-Bind: a structure-based method for accurate identification of RNA-protein binding sites. Sci Rep 7:614
Liu, Keqin; Beck, Dominik; Thoms, Julie A I et al. (2017) Annotating function to differentially expressed LincRNAs in myelodysplastic syndrome using a network-based method. Bioinformatics 33:2622-2630
Yu, Wenshuai; Zhao, Shengjie; Wang, Yongcui et al. (2017) Identification of cancer prognosis-associated functional modules using differential co-expression networks. Oncotarget 8:112928-112941